Sign In
Buy ZTS
$74.17
-1.16 (-1.54%)
At Close: Jul 22, 2026
Artisan Global Opportunities Fund Q4 2025 Portfolio Update
09:39am, Thursday, 29'th Jan 2026
Among our top contributors in Q4 were Argenx, Lam Research and Insmed. Among our biggest detractors in Q4 were Oracle, Netflix and BAE Systems. During the quarter, we initiated new positions in RTX (R
Bank of New York Mellon Corp Decreases Stake in Zoetis Inc. $ZTS
04:28am, Thursday, 29'th Jan 2026
Bank of New York Mellon Corp decreased its holdings in Zoetis Inc. (NYSE: ZTS) by 24.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Tuesday, 27'th Jan 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cullen Frost Bankers Inc. Has $5.07 Million Stake in Zoetis Inc. $ZTS
05:06am, Monday, 26'th Jan 2026
Cullen Frost Bankers Inc. reduced its stake in Zoetis Inc. (NYSE: ZTS) by 21.0% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i
Zoetis: Undervalued And Oversold
08:00am, Saturday, 24'th Jan 2026
Zoetis, the global animal health leader, is deeply undervalued at a 19x forward P/E versus its 10-year average of 31.8x. ZTS is positioned to benefit from the secular trend of pet humanization, with 6
Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Thursday, 22'nd Jan 2026
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Healthcare Stocks Poised for a Comeback in 2026
01:05pm, Thursday, 22'nd Jan 2026
Don't wait too long to press the buy button on these comeback stories.
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years
12:00pm, Thursday, 22'nd Jan 2026
Trading at a once-in-a-decade low valuation, this leading animal healthcare stock deserves a long look from investors.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Thursday, 22'nd Jan 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Dynasty Wealth Management LLC Trims Stock Position in Zoetis Inc. $ZTS
04:43am, Wednesday, 21'st Jan 2026
Dynasty Wealth Management LLC decreased its stake in Zoetis Inc. (NYSE: ZTS) by 82.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Market Today: Netflix's WBD Bid, Tech Selloff, AI at Davos
05:35pm, Tuesday, 20'th Jan 2026
Guru Stock PicksChuck Royce has made the following transactions:Reduce in APYX by 1.27%Add in EBF by 4.13%New position in ANDGSmead Value Fund has made the foll
Zoetis Inc. $ZTS Position Boosted by Davis Rea LTD.
04:56am, Friday, 16'th Jan 2026
Davis Rea LTD. increased its holdings in Zoetis Inc. (NYSE: ZTS) by 10.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The instituti
Zoetis: Cheap Valuation And Attractive Product Launch Pipeline
08:22am, Wednesday, 14'th Jan 2026
I rate Zoetis (ZTS) a buy, citing a robust pipeline, upcoming product launches, and discounted valuation versus peers. ZTS targets new therapeutic white spaces—oncology, cardiology, and renal diseas
Ashton Thomas Securities LLC Grows Stake in Zoetis Inc. $ZTS
03:48am, Wednesday, 14'th Jan 2026
Ashton Thomas Securities LLC raised its position in Zoetis Inc. (NYSE: ZTS) by 760.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 12,76
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
07:15pm, Monday, 12'th Jan 2026
Zoetis (ZTS) reached $125.32 at the closing of the latest trading day, reflecting a -1.45% change compared to its last close.
